Pavel Tyan

Pavel Tyan, MD has over a decade of experience in the pharmaceutical and clinical research industry. Pavel has held key roles at companies like Nanobiotix, Advanced Clinical, and Syneos Health, specializing in oncology. With significant expertise in managing international clinical trials and providing medical oversight, Pavel's work has focused on areas such as solid tumors, ADCs, and dendritic cell therapy. Pavel has also been responsible for scientific evaluation, CRO selection, and protocol-specific medical monitoring.

Pavel Tyan, MD, started their education at Saint Petersburg State Medical Academy named after I.I. Mechnikov, where they obtained their MD in General Medicine from 1994 to 2000. Pavel then pursued further studies at Vladivostok State Medical University, earning another MD in General Medicine from 2000 to 2001. Subsequently, they attended Saint-Petersburg Pavlov State Medical University, focusing on General Surgery and obtaining a degree in Surgeon from 2001 to 2002. Lastly, in 2007, they attended St-Petrersburg State Medical Academy of Postgraduate Education specializing in General Oncology to become an Oncologist. Additionally, Pavel Tyan has obtained several certifications in various fields from reputable institutions over the years.